paradigm-hf: combined neprilysin and renin-angiotensin system (ras) inhibition
Published 9 years ago • 1.2K plays • Length 6:46Download video MP4
Download video MP3
Similar videos
-
37:41
paradigm-hf — the experts’ discussion
-
3:17
paradigm-hf: a concise summary with journal club questions
-
6:22
a look at the paradigm-hf trial
-
8:09
angiotensin receptor neprilysin inhibition in heart failure
-
6:26
consistent benefit of sacubitril/valsartan: more from paradigm-hf
-
18:44
angiotensin neprilysin inhibitor (arni)
-
35:09
neprilysin inhibition: in heart failure and beyond
-
3:43
international academy of cardiology: a.h. jan danser, m.d.: dual at1 receptor/neprilysin inhibition
-
8:09
px chf2017 seg07 neprilysin inhibition
-
27:38
masterclass: neprilysin inhibition in patients with reduced lvef
-
2:39
the renin–angiotensin–aldosterone system, raas, animation
-
16:46
new agents for heart failure: sacubitril/valsartan
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer
-
5:38
paradigm-hf trial
-
4:17
esc 23: liberate-hefh: novel pcsk9-inhibitor in heterozygous familial hypercholesterolemia
-
10:42
nesiritide and angiotensin receptor neprilysin inhibitor : newer treatment for heart failure
-
2:00
renin angiotensin system inhibitors | pharmacology video | medical student | v-learning™
-
8:08
blocking the raas pathway in heart failure